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A 48-year-old man presented with acute right ﬂank pain. A computed tomography
scan revealed right renal infarction. Because he had no thrombosis in the renal
vessels and no clear embolic source, a further examination was performed to ﬁnd
the cause of the renal infarction. On transesophageal echocardiography, a right-
to-left shunt during the Valsalva maneuver established a diagnosis of patent
foramen ovale. This is a case of paradoxical embolism through a PFO leading to
renal infarction.
& 2012. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
A patent foramen ovale (PFO) can act as a pathway for a
thrombus from the peripheral veins, bypassing the lungs
and entering the systemic circulation [1]. A paradoxical
embolism is an uncommon but increasingly recognized
cause of embolic events. A cerebral event is the usual
presenting symptom in patients with PFO. Systemic, non-
cerebral, paradoxical embolisms occur less frequently,
accounting for 5%–10% of all paradoxical embolisms [2].
Renal infarction secondary to paradoxical embolism has
rarely been described, and paradoxical embolism involving
kidneys has been reported to commonly involve multiple
organs, such as the lung, kidneys, and brain [3]. Here, we
report a case of a paradoxical embolism caused by PFO
involving only kidneys.rean Society of Nephrology. P
ses/by-nc-nd/4.0/).
gy, Department of Med-
an University School of
710, Seoul, Korea.
(W Huh).Case report
A 48-year-old Korean man was referred to our hospital with
sudden right ﬂank pain that had begun 10 days earlier. The
patient did not have hypertension, diabetes, or dyslipidemia.
He had been diagnosed with idiopathic thrombocytopenic
purpura (ITP) 10 years earlier, but his platelet counts had been
stable (450,000/mL) with no signiﬁcant bleeding, over the past
10 years. He had undergone a hemorrhoidectomy two months
earlier. He was a 30-pack-year smoker and an occasional
drinker, with no noteworthy family medical history. On admis-
sion, the patient’s blood pressure was 107/68 mm Hg and his
pulse rate was 78 beats/minute. His respiratory rate and body
temperature were 18 breaths/minute and 36.3 1C, respectively.
A physical examination revealed clear breath sounds and a
regular heartbeat with no murmur. There was no tenderness
on either side of his lower back. His neurologic ﬁndings were
normal, and neither edema nor bruising was found on the
lower extremities. Blood test results showed a low platelet
count (white blood count 6,800/mL, hemoglobin 12.4 g/dL,
platelet 63,000/mL), and his serum creatinine was 0.83 mg/dL
and blood urea nitrogen 13.0 mg/dL. Urine microscopy
revealed mild hematuria (red blood cell count 3–5/HPF) andublished by Elsevier. This is an open access article under the CC BY-NC-
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antithrombin III activity, plasminogen activity, protein C activ-
ity, coagulation factor VIII activity, homocysteine, lupus antic-
oagulant, and anticardiolipin antibody were within the normal
ranges, suggesting no abnormality of the coagulation system.
A contrast-enhanced abdominal computed tomography (CT)
scan was performed in the previous hospital, showing no
stones, but a wedge-shaped perfusion defect was detected
in the right kidney, suggestive of renal infarction (Fig. 1).
Contrast-enhanced abdominal magnetic resonance (MR) angio-
graphy was performed to exclude the possibility of a renal
artery thrombus or dissection. Both renal arteries were patent,
with no signiﬁcant stenosis or atherosclerosis (Fig. 2A) but
several cortical scars were detected on the left kidney (Fig. 2B).
Because the patient’s renal arteries were intact despite acute
renal infarction, the ﬁlling defect was suspected to be caused
by embolization, and the cortical scars on the left kidney
suggested the possibility of previous recurrent renal infraction.
A duplex lower extremity vein scan showed no obviousFigure 1. Contrast-enhanced abdominal computed tomography
imaging. Wedge-shaped perfusion defect is shown in the right kidney
(arrowheads).
Figure 2. Magnetic resonance angiography imaging. Both renal arteries w
thrombosis and atherosclerotic changes in the renal vessels. (B) Several cortthrombosis in the deep venous system, which is a frequent
potential source of an embolism. Chest contrast-enhanced CT
showed no evidence of a pulmonary thromboembolism. Elec-
trocardiography showed a normal sinus rhythm, and transthor-
acic echocardiography revealed no thrombus, but normal left
ventricular function. However, a contrast study and bubble test
during transesophageal echocardiography revealed a small PFO
(Fig. 3A). From these ﬁndings, a paradoxical embolism through a
small PFO was conﬁrmed as the cause of the patient0s multifocal
renal infarction. The patient had been given intravenous heparin
for his renal infarction in the previous hospital. During the
heparin treatment, he developed hemorrhoidal bleeding, and
underwent hemorrhoid ligation and discontinued anticoagula-
tion. Therefore, PFO closure was planned to prevent further
embolic events and bleeding complications, which can recur
under anticoagulation therapy.Discussion
The diagnosis of acute renal infarction is often missed or
delayed because the disease is both rare and has a nonspeciﬁc
clinical presentation. In a patient with an increased risk of
thromboembolism, unexplained ﬂank pain should raise a
suspicion of acute renal infarction [4]. Diagnostic tests should
be considered for patients who are at risk of systemic
embolization and present with symptoms suggestive of renal
infarct. A contrast-enhanced CT scan should be performed to
look for renal infarction, for which the classic ﬁnding is a
wedge-shaped perfusion defect. Two major causes of renal
infarction are thromboemboli, which usually originate from a
thrombus in the heart or aorta and in situ thrombosis of a
renal artery or renal artery dissection, which is less com-
mon [5]. The major sources of a clot embolism include the left
atrium during atrial ﬁbrillation, a left ventricular thrombus in
patients with myocardial infarction, and thromboemboli ori-
ginating from complex plaques in the aorta. Other potential
embolic sources include valvular vegetations in patients
with infective endocarditis and, rarely, paradoxical embolism
through a PFO [6]. The foramen ovale, which allows blood to
ﬂow across the atrial septum in the fetal stage, normally
closes shortly after birth. However, in approximately 25% ofere patent but several cortical scars were detected. (A) There were no
ical scars on the left lower pole of the kidney were shown (arrowheads).
Figure 3. Bubble contrast transesophageal echocardiography. Agitated saline was injected via a peripheral vein and the bubbles reached the
right atrium. (A) Opaciﬁcation of the right atrium was seen initially and the bubbles (arrowhead) passed into the left atrium through the small
opening in the PFO (arrow) during the Valsalva maneuver. (B) Many bubbles were seen in the left atrium at the end of a sustained Valsalva
maneuver.
H Jeong et al / Renal embolism and patent foramen ovale198adults, closure of the foramen ovale is incomplete. When a
right-to-left shunt exists across the PFO, thrombi, and vasoac-
tive substances formed in the right-side venous circulation
can bypass the lung ﬁlter and enter the left arterial system,
causing a paradoxical embolism [7]. Although the vast major-
ity of people with PFO are asymptomatic, the presence
of PFO has been implicated in stroke, migraine headache,
decompression sickness, high-altitude pulmonary edema, and
platypnea-orthodeoxia syndrome [8]. Although ischemic events
can occur in most organs, including the brain, eyes, kidneys,
spleen, and intestines, and in the upper and lower extremities,
stroke is the most usual common manifestation of paradoxical
embolism. The prevalence of PFO is estimated to be 45% among
patients with cryptogenic stroke or transient ischemic
attacks [9]. In a recent study the most common reason for the
primary referral of patients with PFO-related conditions for PFO
closure (n¼416) was cryptogenic stroke (n¼219). Noncerebral
paradoxical embolism was rare (n¼12) and 75% of noncerebral
embolisms were myocardial infarctions (n¼8) [1]. Whereas
myocardial infarction is a rare complication of paradoxical
embolism through PFO, there are even fewer reports of renal
infraction in patients with PFO [10]. Most patients reported with
paradoxical renal infarction present with multiorgan involve-
ment and have multiple acute ischemic symptoms, such as
dyspnea and abdominal pain [11]. This case is unique in that the
patient had acute ﬂank pain and the embolism was conﬁrmed
only in the kidneys, with no other organ involvement. Secondary
prophylaxis for a paradoxical embolism can involve pharma-
cotherapy or the closure of the right-to-left shunt, which can be
performed surgically or with a transcatheter procedure [12]. The
efﬁcacy of the devices used to prevent recurrent systemic
arterial embolisms, and in particular cerebrovascular embo-
lisms, is unknown but is currently under investigation in
large-scale clinical trials [8]. Closure of the PFO after the ﬁrst
embolism is recommended for patients at high risk
of recurrent embolic events. The risk factors associated with
embolic recurrence include atrial septal aneurysm, high shunt-
ing volume, and shunting at rest. Other risk factors include large
PFO (more than 3.4 mm), higher mobility of the PFO valve, a
well developed Eustachian valve, a Valsalva maneuver immedi-
ately prior to event, and a history of recurrent embolic events
[13]. Bissessor et al. reviewed 70 percutaneous PFO procedures
prospectively. PFO can be closed percutaneously with a low rate
of signiﬁcant residual shunting and very few complications.After closure of the PFO, no patient experienced a recurrent
paradoxical embolic event during the medium-term (up to four
years) follow-up period [9].
In this case, the patient also had long-standing ITP when
his renal infarction occurred. His platelet count had not
changed for 10 years, without treatment. Given that his
coagulation proﬁle was normal and there was no thrombosis
in the renal artery, it is unlikely that ITP was associated
with his renal infarction. Because he had no obvious source of
emboli, we used contrast echocardiography and a bubble test
during the Valsalva maneuver to examine the possibility of a
paradoxical embolism and conﬁrmed the diagnosis of para-
doxical renal infarction caused by PFO. The patient has two
risk factors for recurrent embolic event. Echocardiography
shows that he has a shunting not only at Valsalva but also at
rest. And the patient was suspected of having had recurrent
renal infractions in the past based on MR angiography ﬁnd-
ings. So, secondary prophylaxis was required to prevent
additional embolisms. Because he suffered hemorrhoidal
bleeding during heparin treatment and his platelet count
was low, the insertion of a transcatheter PFO closure device
was planned, considering the potential problems associated
with maintaining oral anticoagulation therapy.
In conclusion, the role of PFO as a source of ischemic
events in various organs is becoming increasingly evident.
This case suggests that renal infarction can be caused by a
paradoxical embolus from a PFO. Paradoxical embolism is a
rare cause of renal infarction, but immediate recognition of a
paradoxical embolus is very important so that anticoagulation
or device closure can prevent further embolic infarctions in
other organs, as well as in the kidneys. If renal infarction
occurs repeatedly, with no evident cause of the thromboem-
bolism or during anticoagulation therapy, a paradoxical
embolism through a PFO should be considered.Conﬂict of interest
No conﬂict of interest
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